144 related articles for article (PubMed ID: 3858014)
21. Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment.
Schrøder H; Clausen N; Ostergaard E; Pressler T
Cancer Chemother Pharmacol; 1986; 16(2):190-3. PubMed ID: 3456283
[TBL] [Abstract][Full Text] [Related]
22. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
[TBL] [Abstract][Full Text] [Related]
23. Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.
Bond JH; Levitt MD; Prentiss R
J Lab Clin Med; 1975 Apr; 85(4):546-55. PubMed ID: 1120927
[TBL] [Abstract][Full Text] [Related]
24. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon.
Read NW; McFarlane A; Kinsman RI; Bates TE; Blackhall NW; Farrar GB; Hall JC; Moss G; Morris AP; O'Neill B
Gastroenterology; 1984 Feb; 86(2):274-80. PubMed ID: 6690354
[TBL] [Abstract][Full Text] [Related]
25. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia.
Kearney PJ; Light PA; Preece A; Mott MG
Cancer Chemother Pharmacol; 1979; 3(2):117-20. PubMed ID: 292536
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate.
Sonneveld P; Schultz FW; Nooter K; Hählen K
Cancer Chemother Pharmacol; 1986; 18(2):111-6. PubMed ID: 3791556
[TBL] [Abstract][Full Text] [Related]
27. Is the transit time of a meal through the small intestine related to the rate at which it leaves the stomach?
Read NW; Cammack J; Edwards C; Holgate AM; Cann PA; Brown C
Gut; 1982 Oct; 23(10):824-8. PubMed ID: 7117901
[TBL] [Abstract][Full Text] [Related]
28. Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood.
Gwavava NJ; Pinkerton CR; Glasgow JF; Sloan JM; Bridges JM
J Clin Pathol; 1981 Jul; 34(7):790-5. PubMed ID: 6943149
[TBL] [Abstract][Full Text] [Related]
29. The effect of methotrexate on the bioavailability of oral 6-mercaptopurine.
Balis FM; Holcenberg JS; Zimm S; Tubergen D; Collins JM; Murphy RF; Gilchrist GS; Hammond D; Poplack DG
Clin Pharmacol Ther; 1987 Apr; 41(4):384-7. PubMed ID: 3470165
[TBL] [Abstract][Full Text] [Related]
30. Competitive inhibition between folic acid and methotrexate for transport carrier in the rat small intestine.
Chungi VS; Bourne DW; Dittert LW
J Pharm Sci; 1979 Dec; 68(12):1552-3. PubMed ID: 529052
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic significance of systemic clearance of methotrexate in acute lymphoid leukemia in childhood].
Borsi J; Révész T; Schuler D
Orv Hetil; 1986 Feb; 127(8):439-42. PubMed ID: 3456552
[No Abstract] [Full Text] [Related]
32. Relationship between small bowel transit time and absorption of a solid meal. Influence of metoclopramide, magnesium sulfate, and lactulose.
Holgate AM; Read NW
Dig Dis Sci; 1983 Sep; 28(9):812-9. PubMed ID: 6884167
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma.
Ettinger LJ; Chervinsky DS; Freeman AI; Creaven PJ
Cancer; 1982 Nov; 50(9):1676-82. PubMed ID: 6956429
[TBL] [Abstract][Full Text] [Related]
34. Scintigraphy of the small intestine: a simplified standard for study of transit with reference to normal values.
Grybäck P; Jacobsson H; Blomquist L; Schnell PO; Hellström PM
Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):39-45. PubMed ID: 11807605
[TBL] [Abstract][Full Text] [Related]
35. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
[TBL] [Abstract][Full Text] [Related]
36. Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats.
Yokooji T; Mori N; Murakami T
J Pharm Pharmacol; 2009 Jul; 61(7):911-8. PubMed ID: 19589233
[TBL] [Abstract][Full Text] [Related]
37. Use of breath hydrogen (H2) to quantitate small bowel transit time following partial gastrectomy.
Bond JH; Levitt MD
J Lab Clin Med; 1977 Jul; 90(1):30-6. PubMed ID: 874370
[TBL] [Abstract][Full Text] [Related]
38. Small intestinal transit in diabetics.
Scarpello JH; Greaves M; Sladen GE
Br Med J; 1976 Nov; 2(6046):1225-6. PubMed ID: 990859
[TBL] [Abstract][Full Text] [Related]
39. Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in children.
Borsi JD; Moe PJ
Cancer; 1987 Dec; 60(12):3020-4. PubMed ID: 3479231
[TBL] [Abstract][Full Text] [Related]
40. Change in transfer rate of methotrexate from spinal fluid to plasma during intrathecal therapy in children and adults.
Lankelma J; Lippens RJ; Drenthe-Schonk A; Termond EF; van der Kleijn E
Clin Pharmacokinet; 1980; 5(5):465-75. PubMed ID: 6931669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
